Cannabinoid Receptor
Cannabinoid Receptor
Cannabinoid receptors are currently classified into three groups: central (CB1), peripheral (CB2) and GPR55, all of which are G-protein-coupled. CB1 receptors are primarily located at central and peripheral nerve terminals. CB2 receptors are predominantly expressed in non-neuronal tissues, particularly immune cells, where they modulate cytokine release and cell migration. Recent reports have suggested that CB2 receptors may also be expressed in the CNS. GPR55 receptors are non-CB1/CB2 receptors that exhibit affinity for endogenous, plant and synthetic cannabinoids. Endogenous ligands for cannabinoid receptors have been discovered, including anandamide and 2-arachidonylglycerol.
Cannabinoid Receptor Isoform Specific Products
All Product Categories
-
Cannabinoid Receptor Inhibitors
(37)
View all products
-
Cannabinoid Receptor Agonists
(141)
View all products
-
Cannabinoid Receptor Antagonists
(76)
View all products
-
Cannabinoid Receptor Activators
(14)
View all products
-
Cannabinoid Receptor Modulators
(24)
View all products
-
Cannabinoid Receptor Chemical
(1)
View all products
-
Cannabinoid Receptor Inducer
(1)
View all products
-
Cannabinoid Receptor Degrader
(1)
View all products
-
Cannabinoid Receptor Controls
(2)
View all products
-
Cannabinoid Receptor Ligands
(13)
View all products
-
Cannabinoid Receptor Related Products (448)
Related Products (448)
-
Antibodies (1)
-
Cannabinoid Receptor Isoform Comparison
-
Taranabant ((1R,2R)stereoisomer) (Standard)
0 ImagesCat. No.: HY-10013BRCAS No.: 701977-08-4Synonyms: MK0364 (1R,2R)stereoisomer (Standard)Taranabant ((1R,2R)stereoisomer) (Standard) is the analytical standard of Taranabant ((1R,2R)stereoisomer) (HY-10013B). This product is intended for research and analytical applications. Taranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant. Taranabant is a highly potent and selective cannabinoid 1 (CB1) receptor inverse agonist.
-
Δ9-THCBA-A
0 ImagesCat. No.: HY-170739CAS No.: 60007-98-9Synonyms: Δ9-Tetrahydrocannabinolic acid-C4Δ9-THCBA-A (Δ9-Tetrahydrocannabinolic acid-C4) is structurally similar to known phytocannabinoids.
-
HARV-019
0 ImagesCat. No.: HY-184352CAS No.: 2488614-26-0HARV-019 is a derivative of plant cannabinoids and belongs to sodium/potassium ion channel regulators or cannabinoid 1 receptor (b) regulators. HARV-019 can be used for the study of neurological diseases such as neuropathic pain and epilepsy.
-
5'-Hydroxy-9(S)-hexahydrocannabinol
0 ImagesCat. No.: HY-170042CAS No.: 127349-00-25'-Hydroxy-9(S)-hexahydrocannabinol is structurally similar to known phytocannabinoids.
-
5Z,8Z,11Z,14Z-Eicosatetraenoic acid, 3-thienylmethyl ester
0 ImagesCat. No.: HY-121830CAS No.: 390824-17-65Z,8Z,11Z,14Z-Eicosatetraenoic acid, 3-thienylmethyl ester is a Anandamide (HY-10863) analog. Anandamide is an endocannabinoid.
-
MEP-FUBICA
0 ImagesCat. No.: HY-172082CAS No.: 2749985-70-2MEP-FUBICA is structurally categorized as a synthetic cannabinoid.
-
Cannabifuran
0 ImagesCat. No.: HY-W714389CAS No.: 56154-58-6Cannabifuran is structurally similar to known phytocannabinoids.
-
1-(1-Methyl-1H-indol-3-yl)-2-(1-naphthalenyl)ethanone
0 ImagesCat. No.: HY-W748362CAS No.: 1638677-49-21-(1-Methyl-1H-indol-3-yl)-2-(1-naphthalenyl)ethanone is structurally similar to known synthetic cannabinoids.
-
PF-514273
0 ImagesCat. No.: HY-12104CAS No.: 851728-60-4PF-514273 is an orally active, selective antagonist for cannabinoid-1 receptor (CB1) with IC50 of 1 nM. PF-514273 reduces the food uptake in mice, and can be used for obesity research.
-
ADB-BICA
0 ImagesCat. No.: HY-172069CAS No.: 2219319-40-9ADB-BICA is structurally classified as a synthetic cannabinoid.
-
BZO-CHMOXIZID
0 ImagesCat. No.: HY-W754600CAS No.: 1048973-67-6Synonyms: CHM-MDA-19BZO-CHMOXIZID is a Cannabinoid-like analog.
-
Azidoindolene 1
0 ImagesCat. No.: HY-126550CAS No.: 1364933-69-6Azidoindolene 1 is structurally similar to cannabinoid.
-
Arachidonoyl 2'-fluoroethylamide
0 ImagesCat. No.: HY-134224CAS No.: 166100-37-4Arachidonoyl 2'-fluoroethylamide is an anandamide analog. Arachidonoyl 2'-fluoroethylamide has the potential for the research of intraocular hypertension.
-
(±)-6',7'-Epoxy cannabichromene
0 ImagesCat. No.: HY-170040CAS No.: 134840-95-2(±)-6',7'-Epoxy cannabichromene is a phytocannabinoid metabolite.
-
5-Fluoro PB-22 3-carboxyindole metabolite
0 ImagesCat. No.: HY-114553CAS No.: 1432794-98-3Synonyms: 5F-PB-22 3-carboxyindole metabolite5-Fluoro PB-22 3-carboxyindole metabolite (5F-PB-22 3-carboxyindole metabolite) is a metabolite of 5-fluoro PB-22. 5-Fluoro PB-22 is a synthetic cannabinoid.
-
MDA 19 (Standard)
0 ImagesSynonyms: BZO-HEXOXIZID (Standard)MDA 19 (Standard) is the analytical standard of MDA 19. This product is intended for research and analytical applications. MDA 19 is a potent and selective agonist of human cannabinoid receptor 2 (CB2), with a Ki of 43.3 nM. MDA 19 has antiallodynic effects in a rat model of neuropathic pain and does not affect rat locomotor activity.
-
N-Arachidonyldopamine (Standard)
0 ImagesCat. No.: HY-110018RCAS No.: 199875-69-9N-Arachidonyldopamine (Standard) is the analytical standard of N-Arachidonyldopamine (HY-110018). This product is intended for research and analytical applications. N-Arachidonyldopamine is a potent and selective endogenous CB1 receptor agonist with a Ki of 250 nM. N-Arachidonyldopamine is also a potent and selective TRPV1 agonist an with EC50 of ~ 50 nM.
-
BB-223-carboxyindole metabolite
0 ImagesCat. No.: HY-118790CAS No.: 858515-71-6Synonyms: B-223-CarboxyindolemetaboliteBB-223-carboxyindole metabolite (B-223-Carboxyindolemetabolite) is a metabolite of BB-22. BB-22 is an analog of cannabinoid.
-
A-836339 (Standard)
0 ImagesA-836339 (Standard) is the analytical standard of A-836339. This product is intended for research and analytical applications.
-
b-AEA (Standard)
0 ImagesCat. No.: HY-103329RCAS No.: 956605-71-3Synonyms: MM22 (Standard); Biotinylated N-arachidonoylethanolamine (Standard)b-AEA (Standard) is the analytical standard of b-AEA (HY-103329). This product is intended for research and analytical applications. b-AEA (MM22) is a biotinylated endocannabinoid analog with probe activity. b-AEA is able to accumulate intracellularly in a similar manner to the parent compound AEA. b-AEA does not interact with other components of the endocannabinoid system and therefore does not interfere with their function. b-AEA can be used to visualize the accumulation and intracellular distribution of endocannabinoids.
